Ping Peng

Ping Peng is a seasoned professional in the field of non-clinical safety and toxicology with extensive experience across various companies in the biopharmaceutical industry. Currently serving as Director of Non-Clinical Safety at Genmab since March 2022, Ping Peng previously held significant roles at Janssen Inc. as Non-Clinical Safety Lead and Associate Scientific Director in Biologics Toxicology from May 2016 to March 2022, where responsibilities included providing strategic input on Biologics Toxicology programs and expert advice on safety assessments. Additional roles include Director of Toxicology at Sage Therapeutics and Purdue Pharma, and leadership positions at several other pharmaceutical companies. Educational background includes a Ph.D. in Immunology from the University of Connecticut, a Master's degree in Cell Biology from Fordham University, and a Bachelor's degree in Microbiology from Wuhan University.